Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01292655
Title Study to Evaluate the Safety and Tolerability of IV Doses of BMS-906024 in Subjects With Advanced or Metastatic Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Bristol-Myers Squibb
Indications

lung non-small cell carcinoma

melanoma

pancreatic cancer

Her2-receptor negative breast cancer

ovarian cancer

Advanced Solid Tumor

Therapies

BMS-906024

Age Groups: adult
Covered Countries USA | CAN

Additional content available in CKB BOOST